Position
Chief Executive Officer
Company
Kesmalea Therapeutics
LondonBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Kesmalea Therapeutics has announced the appointment of Robert Johnson as its Chief Executive Officer. Johnson will lead the company’s growth phase, focusing on a new small molecule approach to targeted protein degradation. The company aims to address the challenges associated with large protein degraders and broaden the applications of targeted protein degradation into important disease areas.
Quick answer
Kesmalea Therapeutics Appoints Robert Johnson as Chief Executive Officer (November 7, 2024). Kesmalea Therapeutics is based in London, England, United Kingdom.
- Who is the new Chief Executive Officer at Kesmalea Therapeutics?
- Kesmalea Therapeutics named Robert Johnson Chief Executive Officer, announced November 7, 2024.
- What did Kesmalea Therapeutics announce on November 7, 2024?
- Kesmalea Therapeutics has announced the appointment of Robert Johnson as its Chief Executive Officer. Johnson will lead the company’s growth phase, focusing on a new small molecule approach to targeted protein degradation.
- What does Kesmalea Therapeutics do?
- Kesmalea Therapeutics is a biopharmaceutical company focused on developing a pipeline of novel therapeutics based on transforming large protein degraders into small molecules.
- Where is Kesmalea Therapeutics based?
- Kesmalea Therapeutics is based in London, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Tarsus Pharmaceuticals (November 5, 2024), Altimmune (November 11, 2024), Alkeus Pharmaceuticals (October 31, 2024) and Arecor Therapeutics PLC (November 18, 2024) also announced leadership changes within 45 days of Kesmalea Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu, M.D., as Chief Medical Officer (November 5, 2024)
- Altimmune Appoints Greg Weaver as Chief Financial Officer (November 11, 2024)
- Alkeus Pharmaceuticals Appoints David Arkowitz as Chief Financial Officer (October 31, 2024)
- Arecor Therapeutics PLC Appoints David Ellam as Interim Chief Financial Officer to Succeed Susan Lowther (November 18, 2024)
- NRx Pharmaceuticals Appoints Michael Abrams as Chief Financial Officer (November 18, 2024)
- Byondis Appoints Louis Denis, M.D. as Chief Medical Officer (November 19, 2024)
Who to call at Kesmalea Therapeutics, and when
A new leader at Kesmalea Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kesmalea Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kesmalea Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kesmalea Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kesmalea Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kesmalea Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.